New York Life Investment Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-27,428
Closed -$510K 863
2024
Q3
$510K Sell
27,428
-8,548
-24% -$144K 0.01% 809
2024
Q2
$554K Buy
35,976
+2,703
+8% +$38.6K 0.01% 795
2024
Q1
$491K Sell
33,273
-734
-2% -$10.2K ﹤0.01% 788
2023
Q4
$485K Buy
+34,007
New +$483K 0.01% 861
2022
Q3
Sell
-67,716
Closed -$946K 1256
2022
Q2
$946K Buy
+67,716
New +$905K 0.01% 628

Other funds holding SBRA

New York Life Investment Management's SBRA Position: Q4 2024 in Review

New York Life Investment Management sold out of Sabra Healthcare REIT (SBRA) in Q4 2024, closing a stake of 27,428 shares — an estimated $510K sold.

New York Life Investment Management first reported a position in SBRA in Q2 2022 and held it in 5 quarters. The position peaked at $946K in Q2 2022. 389 funds tracked by Wall St. Rank hold SBRA as of Q4 2024.

  • New York Life Investment Management reported no remaining Sabra Healthcare REIT position as of Q4 2024 after selling out during the quarter.
  • New York Life Investment Management sold 27,428 Sabra Healthcare REIT shares in Q4 2024, an estimated $510K.
  • New York Life Investment Management first reported a position in Sabra Healthcare REIT in Q2 2022 and held it in 5 quarters.
  • New York Life Investment Management's Sabra Healthcare REIT position peaked at $946K in Q2 2022.
  • 389 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2024.

Based on New York Life Investment Management's 13F filing for Q4 2024, filed 5 Feb 2025.